ProtEmbo CPS for TAVR
Cerebral embolic protection during Transcatheter Aortic Valve Replacement
Phase 3Active
Key Facts
Indication
Cerebral embolic protection during Transcatheter Aortic Valve Replacement
Phase
Phase 3
Status
Active
Company
About Protembis
Protembis is a private, clinical-stage medical device company focused on cerebral protection during TAVR procedures. Its lead product, the ProtEmbo Cerebral Protection System (CPS), is designed to filter embolic debris to prevent large, clinically meaningful brain infarcts. The company is currently conducting a pivotal FDA IDE trial, has demonstrated promising safety and efficacy in European studies, and is backed by significant financing from the European Investment Bank and other investors to advance its clinical and commercial goals.
View full company profile